TABLE 2.

Pathologic Features and Clinical Outcomes of Incidental Carcinomas Detected at RRSO from 3 Institutions

Age*	Institut ion	Pathology	Chemotherapy**	Recurrence	Current Status	Years of Followup
Group I
41	BWH	HGTIN	No	No	Alive	5
41	BWH	HGTIN	No	No	Alive	1
44	BWH	HGTIN	Yes	No	Alive	8
46	BWH	HGTIN	No	Yes - positive ascites cytology and elevated CA-125; 4 yrs after BSO	Alive	6
51	BWH	HGTIN	No	No	Lost to followup 2009	<1
53	FHCRC	HGTIN	NO	NO	Alive	3
49	UMICH	HGTIN	No	No	Alive	2
37	UMICH	HGTIN	No	No	Alive	2
53	FHCRC	HGTIN	No	No	followup 2011	7
60	BWH	HGTIN	Yes	No	Alive	7
66	BWH	HGTIN	Yes (2 cycles)	No	Alive	8
Group II
57	BWH	HGTIN and focal invasive tubal carcinoma	Yes	No	Expired 2010 (metastatic breast cancer)	2
57	FHCRC	HGTIN and invasive tubal carcinoma	Yes	No	Alive	6
67	FHCRC	HGTIN and invasive tubal carcinoma	Yes (3 cycles)	Yes – elevated CA-125; 5 yrs after BSO	Alive	6
60	FHCRC	HGTIN (2 foci) and metastatic carcinoma on ovarian surface	Yes	No	Alive	5
49	UMICH	HGTIN with associated invasive carcinoma and positive peritoneal cytology	Yes	No	Alive	<1
43	BWH	HGTIN and positive peritoneal cytology	Yes	No	Alive	8
48	BWH	HGTIN and metastatic carcinoma on ovarian surface, positive peritoneal cytology	Yes	No	Alive	4
56	BWH	HGTIN and metastatic carcinoma on ovarian surface	Yes	No	Alive	<1
56	BWH	HGTIN and metastatic carcinoma on ovarian surface	Yes	No	Alive	1
65	BWH	HGTIN and metastatic carcinoma on ovarian surface, positive peritoneal cytology	Yes	No	Lost to followup 2008	1
76	BWH	HGTIN with associated invasive carcinoma and Multiple serosal metastases, positive peritoneal cytology	Yes	Yes - elevated ca-125 and tissue diagnosis at 6 yrs	Alive	8
49	BWH	Endometrioid adenocarcinom a (moderately differentiated) involving fallopian tube and metastatic carcinoma on ovarian surface	Yes	No	Alive	6
Group III
73	BWH	Invasive serous carcinoma, involving fimbriae	Yes	Yes - elevated CA-125; 5 yrs after BSO	Alive	6
62	BWH	Endometrioid adenocarcinom a (grade 2/3), involving fimbriae	Yes (1 cycle)	No	Alive	8
50	FHCRC	Invasive carcinoma, bilateral fallopian tubes	Yes	No	Alive	6
74	FHCRC	Invasive tubal Carcinoma	Yes (3 cycles)	No	Expired 2008 (pneumonia)	<1
46	BWH	Endometrioid adenocarcinom a (grade 3 of 3) involving ovarian surface and positive peritoneal cytology, abdominal wall nodule	Yes	No	Alive	5
51	BWH	High grade serous carcinoma, involving ovarian surface and positive peritoneal cytology	Yes	No	Alive	4

^*Age at time of prophylactic BSO

^*All chemotherapy patients received 6 courses unless otherwise stated